GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,216,000 | -62.3% | 32,676 | -67.6% | 0.00% | -66.7% |
| Q2 2019 | $5,873,000 | -40.0% | 100,960 | -27.7% | 0.01% | -40.0% |
| Q1 2019 | $9,781,000 | +80.8% | 139,622 | +66.3% | 0.01% | +66.7% |
| Q4 2018 | $5,409,000 | -15.2% | 83,973 | -7.5% | 0.01% | 0.0% |
| Q3 2018 | $6,376,000 | +66.0% | 90,806 | +19.1% | 0.01% | +50.0% |
| Q2 2018 | $3,841,000 | -40.8% | 76,217 | -63.2% | 0.00% | -42.9% |
| Q1 2018 | $6,488,000 | -2.5% | 207,340 | +6.6% | 0.01% | 0.0% |
| Q4 2017 | $6,652,000 | +16.3% | 194,503 | +9.1% | 0.01% | +16.7% |
| Q3 2017 | $5,721,000 | +38.1% | 178,286 | +40.1% | 0.01% | +50.0% |
| Q2 2017 | $4,143,000 | +4.3% | 127,294 | +0.9% | 0.00% | 0.0% |
| Q1 2017 | $3,974,000 | +6.3% | 126,202 | -0.8% | 0.00% | 0.0% |
| Q4 2016 | $3,738,000 | +320.5% | 127,196 | +314.0% | 0.00% | +300.0% |
| Q3 2016 | $889,000 | +21.0% | 30,724 | +8.3% | 0.00% | 0.0% |
| Q2 2016 | $735,000 | – | 28,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |